CLINICAL_TRIALS
withdrawal
· 2012-01-25
Clinical Trial Update: X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee [Phase 3]
Summary
Pfizer reports that the Phase 3 X-ray study of SD-6010 in osteoarthritis of the knee has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Knee Osteoarthritis | Phase 3 | Status: WITHDRAWN